The store will not work correctly when cookies are disabled.
4-oxo-N7-(3'-deoxy-3'-fluoro-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine
ID: ALA4874598
PubChem CID: 156787178
Max Phase: Preclinical
Molecular Formula: C11H12FN3O4
Molecular Weight: 269.23
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]cnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](F)[C@H]1O
Standard InChI: InChI=1S/C11H12FN3O4/c12-7-6(3-16)19-11(8(7)17)15-2-1-5-9(15)13-4-14-10(5)18/h1-2,4,6-8,11,16-17H,3H2,(H,13,14,18)/t6-,7-,8-,11-/m1/s1
Standard InChI Key: RXQKOFXTTCXGSX-KCGFPETGSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
28.9360 -3.6402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7532 -3.6402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0075 -2.8635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3446 -2.3814 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.6858 -2.8635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4548 -4.3007 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.2327 -4.3019 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9085 -2.6114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7851 -2.6121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7383 -1.8121 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.8555 -1.8366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0383 -1.8356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1069 -2.6142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4411 -3.0913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5208 -3.9020 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.2654 -4.2419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9313 -3.7648 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8526 -2.9479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5162 -2.4710 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
1 6 1 6
2 7 1 6
5 8 1 1
3 9 1 1
8 10 1 0
9 14 1 0
13 11 1 0
11 12 2 0
12 9 1 0
13 14 2 0
13 18 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 269.23 | Molecular Weight (Monoisotopic): 269.0812 | AlogP: -0.69 | #Rotatable Bonds: 2 |
Polar Surface Area: 100.37 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.87 | CX Basic pKa: 2.54 | CX LogP: -0.77 | CX LogD: -0.78 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.67 | Np Likeness Score: 0.58 |
References
1. Bouton J, Furquim d'Almeida A, Maes L, Caljon G, Van Calenbergh S, Hulpia F.. (2021) Synthesis and evaluation of 3'-fluorinated 7-deazapurine nucleosides as antikinetoplastid agents., 216 [PMID:33667845] [10.1016/j.ejmech.2021.113290] |